Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-01-22FDA Approved: PROCHLORPERAZINE EDISYLATE — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for Prochlorperazine edisylate from Eugia US LLC. The approval pertains to a supplemental submission…
-
FDA approval · 2025-01-21FDA Approved: BUTALBITAL, ASPIRIN, AND CAFFEINE — Supplemental Application (LGM PHARMA SOLUTIONS, LLC)
The FDA approved a supplemental application for the generic fixed-dose combination of butalbital, aspirin, and caffeine. The product is manu…
-
CLINICAL_TRIALS research · 2025-01-17Clinical Trial Update: Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult [NA]
Clinical trial investigating ultrasound-guided stellate ganglion block for chronic migraine in adults is currently recruiting at Beijing Tia…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine
A completed Pfizer-sponsored trial examines the reliability of rimegepant compared with triptans for acute treatment of migraine, with resul…
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Childhood Migraine Treatment Noninvasive Pulsed Radiofrequency vs Flunarizine
This pediatric migraine trial comparing noninvasive pulsed radiofrequency to flunarizine is currently ACTIVE_NOT_RECRUITING.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Integrative and Complementary Therapy for Episodic Migraine and Tension-type Headache
ClinicalTrials.gov record shows a study sponsored by Kliniken Essen-Mitte evaluating integrative and complementary therapy for episodic migr…
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: Digital CBTI for Comorbid Insomnia in Chronic Migraine [NA]
A clinical trial update describes a digital cognitive behavioral therapy program for insomnia in people with chronic migraine, with the stud…
-
FDA approval · 2025-01-07FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Baxter Healthcare Corporation)
The FDA approved Baxter Healthcare Corporation's dihydroergotamine mesylate as an original ANDA generic product. The approval covers the gen…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Study to Evaluate the Efficacy of Intranasal Kinetic Oscillation Stimulation in the Preventive Treatment of Chronic Migraine [NA]
Results from a completed clinical trial evaluating intranasal kinetic oscillation stimulation for preventive treatment of chronic migraine h…
-
CLINICAL_TRIALS trial_result · 2024-12-31Clinical Trial Update: Efficacy and Safety of Middle Meningeal Artery Embolization for Treatment of Intractable Migraine [NA]
The clinical trial evaluating middle meningeal artery embolization for intractable migraine has completed, reporting on its efficacy and saf…
-
FDA approval · 2024-12-31FDA Approved: SUMATRIPTAN — Original Application (Rising Pharma Holdings, Inc.)
FDA approval of a generic Sumatriptan product (Original Application) by Rising Pharma Holdings, Inc. for acute treatment of migraine.
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Closed-loop RTMS for Short-term Migraine Prevention [NA]
This entry reports a clinical trial evaluating closed-loop repetitive transcranial magnetic stimulation (RTMS) for short-term migraine preve…
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: Study of Two Digital Therapeutics for the Prevention of Episodic Migraine Receiving CGRP Therapy (ReMMiD-C) [Phase 3]
Phase 3 trial update showing completion of a study evaluating two digital therapeutics for preventing episodic migraine in patients on CGRP …
-
CLINICAL_TRIALS trial_result · 2024-12-18Clinical Trial Update: GORE® CARDIOFORM Septal Occluder Migraine Clinical Study [NA]
A clinical trial of the GORE CARDIOFORM Septal Occluder for migraine associated with patent foramen ovale has been terminated.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Intervention for Sleep and Pain in Youth: a Randomized Controlled Trial [NA]
A randomized controlled trial to evaluate an intervention for sleep and pain in youth, focusing on insomnia and migraine/headache disorders;…
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: NYU Langone Health Headache Center Learning Migraine Self-Management Techniques Study [NA]
A completed clinical trial at NYU Langone Health Headache Center evaluating migraine self-management techniques.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
A Yale-led clinical trial update recruiting participants to study a computer game, qualitative methods, and MEG/EEG assessment of serotonerg…
-
FDA approval · 2024-12-12FDA Approved: SUMATRIPTAN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Sumatriptan from Hikma Pharmaceuticals USA Inc., updating the regulatory status of this prod…
-
FDA approval · 2024-12-12FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for NURTEC ODT (rimegepant sulfate) from Pfizer Laboratories Div Pfizer Inc, related to the prod…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: The Real-world Study of Rimegepant Treatment in Female Migraine Patients of China
Real-world study evaluating rimegepant treatment in female migraine patients in China; the trial status is not yet recruiting.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: CGRP Inhibition, Autonomic Function, and Migraine
This clinical trial update reports ongoing recruitment for a study examining CGRP inhibition, autonomic function, and migraine. The study in…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: Filter Lenses for the Prevention of Migraine Attacks [NA]
A clinical trial is evaluating filter lenses to prevent migraine attacks. Recruitment is not yet started.
-
CLINICAL_TRIALS trial_result · 2024-12-06Clinical Trial Update: Emotional Awareness and Expression Therapy (EAET) for Migraine [NA]
Trial evaluating Emotional Awareness and Expression Therapy (EAET) for migraine has been terminated.
-
FDA approval · 2024-12-05FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for divalproex sodium submitted by Unichem Pharmaceuticals (USA), Inc. under ANDA079163. This ac…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine [NA]
Clinical trial update reporting the completion of a study combining transcranial direct current stimulation with CGRP-pathway monoclonal ant…